EGFR and neoplasm: Future studies in these fields may also provide new important findings on the involvement of canonical and non-canonical ErbB signaling in the modulation of the tumor microenvironment, useful for the optimization of therapeutic strategies based on the combination of ErbB-targeting agents and immunotherapy approaches.